Dong-A ST

64 Cheonhodaero
Dongdaemun-gu
Seoul

Tel: 82-2-920-8111

Show jobs for this employer

About Dong-A ST

Dong-A ST Co., Ltd. specializes in the discovery, development, manufacture and markets pharmaceutical products and medical devices worldwide. The company offers various ethical drugs, including Stillen (Gastritis 2002); Zydena (Erectile dysfunction treatment, 2005); Motilitone (Functional dyspepsia, 2011); Suganon (DPP-4 inhibitor, 2016) as well as biologics and biosimilar products. Once-daily IV/oral Sivextro (Tedizolid, ABSSSI) was also developed by Dong-A ST which was approved by US FDA and launched in US (2014) and EU (2015) by global partner.
YEAR FOUNDED:
1932
LEADERSHIP:
CEO: Soo-Hyoung Kang

5 articles about Dong-A ST